NovoCure20Limited  (NVCR) - NASDAQGS

  Revenue / EPS Summary *  
 
 Fiscal Quarter 2017
(Fiscal Year)
2016
(Fiscal Year)
2015
(Fiscal Year)
March      
   Revenue $34,880(t) $13,053(t)  
   EPS -0.21 (3/31/2017) -0.42 (3/31/2016)  
   Dividends N/A N/A  
June      
   Revenue $38,376(t) $17,919(t)  
   EPS -0.24 (6/30/2017) -0.48 (6/30/2016)  
   Dividends N/A N/A  
September      
   Revenue $50,109(t) $21,674(t) $8,953(t)
   EPS -0.12 (9/30/2017) -0.39 (9/30/2016) -2.09 (9/30/2015)
   Dividends N/A N/A N/A
December  (FYE)      
   Revenue $53,661(t) $30,242(t) $12,383(t)
   EPS -0.13 (12/31/2017) -0.25 (12/31/2016) 2.54 (12/31/2015)
   Dividends N/A N/A N/A
Totals      
   Revenue $177,026(t) $82,888(t) $21,336(t)
   EPS -0.7 -1.54 0.45
   Dividends N/A N/A N/A
Next 3 Years    Previous 3 Years
 
 
©2021, EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.